|
|||||
|
|
The use of the anti-tumour necrosis factor monoclonal antibody—infliximab—to treat ulcerative colitis: implications and trends beyond the available data |
|
| Authors: | S. Rossetti G. C. Actis M. Fadda M. Rizzetto A. Palmo |
| Affiliation: | Division of Gastroenterology, Department of Digestive and Nutritional Diseases, "Molinette" Hospital, Corso Bramante 88, 10126 Turin, Italy. simona.rossetti@flv.com |
| Abstract: | |
| Keywords: | Immune suppressive drugs Inflammatory bowel disease Infliximab Ulcerative colitis |
| 本文献已被 ScienceDirect 等数据库收录！ | |